Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06655454 · ClinicalTrials.gov registry record · Phase 2
Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment
A Phase 2 study of Quality of Life (QOL) and Pain Assessment, sponsored by New York University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06655454: Recruiting Phase 2 study of Quality of Life (QOL) and Pain Assessment, sponsored by New York University.
NCT06655454 is a Phase 2 study of Quality of Life (QOL) and Pain Assessment that is actively recruiting participants, run by New York University. The registered enrollment target is 150 participants, above the 103-participant average among 3 other Quality of Life (QOL) trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06655454, a Phase 2 study of Quality of Life (QOL) and Pain Assessment, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will investigate the impact of an additional injection of long-acting anesthetic on pain level, quality of life, and use of pain medication after a nonsurgical endodontic treatment. The long-acting anesthetic will be compared to a mock injection group and a group with no additional anesthetic to determine any differences in effects.
Primary Outcome
Quality of life will be measured with a modified version of the OHIP-14 questionnaire. For each question, the answers correspond with a scale that runs from 0-4. A higher score corresponds with a lower quality of life, with 0 being great quality of life and 4 being very poor quality of life.
Conditions Studied
Interventions
- DRUG Supplemental Postoperative Bupivacaine
- DRUG Placebo Injection
Study Locations (1)
New York
- New York University College of Dentistry - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 2 |
What NCT06655454 shows while recruiting
NCT06655454 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 103-participant average among 3 other Quality of Life (QOL) trials with a reported enrollment target (46% higher).
The record links to 3 conditions, with Quality of Life (QOL) appearing as the primary indexed condition, and to 2 interventions - of which Supplemental Postoperative Bupivacaine is the first listed.
NCT06655454 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06655454 about?
NCT06655454 is a clinical study titled "Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment". The study will investigate the impact of an additional injection of long-acting anesthetic on pain level, quality of life, and use of pain medication after a nonsurgical endodontic treatment. The long-acting anesthetic will be compared to a mock injection group and a group with no additional anesthe...
What is the current status of trial NCT06655454?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2024-11-01. Estimated completion is 2025-12-01.
What conditions does trial NCT06655454 study?
This clinical trial studies the following conditions: Quality of Life (QOL), Pain Assessment, Analgesic Use.
What interventions are being tested in trial NCT06655454?
The interventions under investigation include: Supplemental Postoperative Bupivacaine (DRUG), Placebo Injection (DRUG).
Who is sponsoring clinical trial NCT06655454?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06655454 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Quality of Life (QOL)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI